Role of second transurethral resection in determining residual tumor in nonmuscle-invasive bladder cancer
Introduction: Presence of residual tumors is not an uncommon event after transurethral resection of bladder tumor, and no studies from Nepal so far has addressed this issue. We conducted this study to determine the rate of residual tumors after first transurethral resection of nonmuscle-invasive bl...
Guardado en:
Autores principales: | Pukar Maskey, Pawan Raj Chalise, Uttam Kumar Sharma, Prem Raj Gyawali, Guna Kumar Shrestha, Bhola Raj Joshi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Surgeons of Nepal
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c13a1084b354378bcb0e4e252ebc567 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer
por: Mohamed Adel Atta, et al.
Publicado: (2017) -
A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer
por: Xu Shi, et al.
Publicado: (2021) -
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Hongda Zhao, et al.
Publicado: (2021) -
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
por: Matteo Ferro, et al.
Publicado: (2021) -
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021)